SCHEMBL7657629

SCHEMBL7657629

O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2cc(F)ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.54
CYP2C9 P11712 3/20 0.54
CYP2D6 P10635 2/20 0.54
POLB P06746 1/20 0.53
RAB9A P51151 1/20 0.53
TDO2 P48775 1/20 0.53
KDM4E B2RXH2 2/20 0.51
LMNA P02545 2/20 0.51
ALDH1A1 P00352 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
MAPT P10636 2/20 0.49
GABRA1 P14867 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
GABRB2 P47870 1/20 0.47
CYP3A4 P08684 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3843612 0.86 POLB (0.71) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL1559452 0.83 POLB (0.51) POLBRAB9ATDO2KDM4ELMNA
SCHEMBL7652677 0.83 CYP2C9 (0.50) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL1558352 0.81 ALDH1A1 (0.69) POLBRAB9ATDO2KDM4ELMNA
SCHEMBL6446945 0.80 CYP2C19 (0.73) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL7652683 0.79 CYP2C9 (0.48) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL4247829 0.78 CYP2C9 (0.52) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL11010527 0.77 DRD2 (0.56) POLBTDO2KDM4EALDH1A1MEN1
SCHEMBL7658624 0.77 POLB (0.65) CYP2C19CYP2C9CYP2D6POLBRAB9A
SCHEMBL18324753 0.76 HDAC1 (0.59) TDO2ALDH1A1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469006-B1 PARTICULARLY FOR TREATING HIV INFECTIONS BRISTOL-MYERS SQUIBB COMPANY 2002-10-22 US disclosed
EP-1105135-A4 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2001-12-12 EP disclosed
EP-1105135-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-06-13 EP disclosed
WO-2000076521-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-12-21 WO disclosed